ResearcherBeijing Tian Tan HospitalNo recent work listed
Weijia Wang
Matched on ORCID iD 0000-0002-8723-0348; OpenAlex author ID A5100460469. Sources: OpenAlex.
Their work
- Papers
- 2
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 4
2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper
Papers 2
- Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing pancreatic cancer. Co-author DOI 10.1080/07853890.2023.2242247↗
- Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.3389/fonc.2020.618215↗
Closest collaborators
The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Chunyi Hao · 2 shared papers, 2020–2023 · strength 0.30
- Paper Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing… DOI 10.1080/07853890.2023.2242247↗
- Paper Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinom… DOI 10.3389/fonc.2020.618215↗
- Jianhui Wu · 2 shared papers, 2020–2023 · strength 0.30
- Paper Identification of the γ-glutamyl cycle as a novel therapeutic target and 5-oxoproline as a new biomarker for diagnosing… DOI 10.1080/07853890.2023.2242247↗
- Paper Identification of an Immune-Related Signature for Predicting Prognosis in Patients With Pancreatic Ductal Adenocarcinom… DOI 10.3389/fonc.2020.618215↗
- Min Zhao · 1 shared paper, 2023 · strength 0.18
- Dao-Ning Liu · 1 shared paper, 2023 · strength 0.18
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.